US 10,376,578 B2
Compositions and methods for treating Crohn's disease and related conditions and infections
Gaurav Agrawal, Manly (AU)
Assigned to Guarav Agrawal, Manly (AU)
Filed by Gaurav Agrawal, Manly (AU)
Filed on Apr. 10, 2017, as Appl. No. 15/483,702.
Application 15/483,702 is a continuation of application No. 14/405,384, granted, now 9,616,121, issued on Apr. 11, 2017, previously published as PCT/AU2013/000587, filed on Jun. 4, 2013.
Claims priority of application No. 2012902307 (AU), filed on Jun. 4, 2012.
Prior Publication US 2017/0274071 A1, Sep. 28, 2017
This patent is subject to a terminal disclaimer.
Int. Cl. A23G 3/36 (2006.01); A23G 4/06 (2006.01); A23G 9/32 (2006.01); A23C 9/123 (2006.01); A61K 33/00 (2006.01); A61K 39/00 (2006.01); A61K 39/40 (2006.01); A61K 31/133 (2006.01); A61K 31/435 (2006.01); A61K 31/496 (2006.01); A61K 31/498 (2006.01); A61K 39/395 (2006.01); A61K 31/4164 (2006.01); A61K 31/7048 (2006.01)
CPC A61K 39/39533 (2013.01) [A23C 9/123 (2013.01); A23G 3/36 (2013.01); A23G 4/06 (2013.01); A23G 9/32 (2013.01); A61K 31/133 (2013.01); A61K 31/4164 (2013.01); A61K 31/435 (2013.01); A61K 31/496 (2013.01); A61K 31/498 (2013.01); A61K 31/7048 (2013.01); A61K 33/00 (2013.01); A61K 39/3955 (2013.01); A61K 39/40 (2013.01); A61K 2039/505 (2013.01); Y02A 50/474 (2018.01)] 5 Claims
OG exemplary drawing
 
1. A therapeutic combination for treating or ameliorating:
a Crohn's Disease, or
a complication of a Crohn's Disease,
comprising:
(1) an anti-TNFα agent, composition or drug, or an agent, a composition or a drug capable of down-modulating or down-regulating a TNFα activity;
(2) an anti-Mycobacterium avium sub species paratuberculosis (MAP) (an anti-MAP) agent, composition, or drug; and
(3) hyperbaric oxygen.